Attached files
| file | filename |
|---|---|
| 10-K - SignPath Pharma, Inc. | v181294_10k.htm |
| EX-31.1 - SignPath Pharma, Inc. | v181294_ex31-1.htm |
| EX-10.15 - SignPath Pharma, Inc. | v181294_ex10-15.htm |
| EX-10.16 - SignPath Pharma, Inc. | v181294_ex10-16.htm |
Exhibit
32.1
CERTIFICATE
PURSUANT TO
18
U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I,
Lawrence Helson, Chief Executive Officer and Chief Financial Officer, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
|
|
1.
|
The
Annual Report on Form 10-K for the year ended December 31, 2009 (the
"Report") fully complies with the requirements of section 13(a) or 15(d)
of the Securities Exchange Act of 1934;
and
|
|
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of SignPath
Pharma Inc.
|
Dated
April 15, 2010
|
By:
|
/s/
Lawrence Helson
|
||
|
Lawrence
Helson, M.D.
|
|||
|
|
Chief
Executive Officer and Chief Financial Officer
|